Pfizer-BioNTech Vaccine
Cross-source consensus on Pfizer-BioNTech Vaccine from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Dosage & preparation
Comparisons
Highlighted claims
- The efficacy figures in the article are based on a two-dose vaccination series. — Pfizer Vaccine Efficacy Against Omicron
- The Pfizer-BioNTech vaccine showed 80% efficacy against infection with the Delta variant. — Pfizer Vaccine Efficacy Against Omicron
- Vaccine efficacy against infection dropped significantly to 33% against the Omicron variant. — Pfizer Vaccine Efficacy Against Omicron
- Vaccine efficacy against hospitalization was 93% with the Delta variant. — Pfizer Vaccine Efficacy Against Omicron
- Efficacy against hospitalization decreased to 70% with the Omicron variant, still constituting strong protection. — Pfizer Vaccine Efficacy Against Omicron
- A three-dose regimen of the Pfizer-BioNTech vaccine would likely yield higher efficacy numbers for both infection and hospitalization prevention. — Pfizer Vaccine Efficacy Against Omicron